{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:51:44Z","timestamp":1784242304578,"version":"3.55.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Seoul National University Hospital Research Fund","award":["620172540"],"award-info":[{"award-number":["620172540"]}]},{"name":"Korea National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology","award":["2014R1A1A2A16055218"],"award-info":[{"award-number":["2014R1A1A2A16055218"]}]},{"name":"Korean Healthcare Technology R&D project funded by the Ministry of Health & Welfare","award":["HI15C1200"],"award-info":[{"award-number":["HI15C1200"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0209593","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T18:29:49Z","timestamp":1547576989000},"page":"e0209593","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study"],"prefix":"10.1371","volume":"14","author":[{"given":"Jiesuck","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-6372","authenticated-orcid":true,"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euijae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonseok","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Ryoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Jin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Hyun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijcard.2017.02.039","article-title":"Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population","volume":"236","author":"SR Lee","year":"2017","journal-title":"Int J Cardiol"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"50","author":"P Kirchhof","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"issue":"23","key":"ref3","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"CT January","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"M Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jcin.2017.02.028","article-title":"Prevalence, management, and long-term (6-year) outcomes of atrial fibrillation among patients receiving drug-eluting coronary stents","volume":"10","author":"HI Choi","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","author":"AL Dans","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"M Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"e0186449","DOI":"10.1371\/journal.pone.0186449","article-title":"Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis","volume":"12","author":"X Gong","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11883-018-0703-4","article-title":"Concomitant use of antiplatelets and anticoagulants in patients with coronary heart disease and atrial fibrillation: what do recent clinical trials teach us?","volume":"20","author":"DH Lam","year":"2018","journal-title":"Curr Atheroscler Rep"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1161\/STROKEAHA.115.009947","article-title":"Non-vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis","volume":"46","author":"KL Wang","year":"2015","journal-title":"Stroke"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/1747493017700663","article-title":"Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"G Ntaios","year":"2017","journal-title":"Int J Stroke"},{"issue":"25","key":"ref12","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"CM Gibson","year":"2016","journal-title":"N Engl J Med"},{"issue":"16","key":"ref13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"CP Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ahj.2018.03.001","article-title":"An open-Label, 2 \u00d7 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and\/or percutaneous coronary intervention: rationale and design of the AUGUSTUS trial","volume":"200","author":"RD Lopes","year":"2018","journal-title":"Am Heart J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ahj.2017.10.009","article-title":"Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: rationale and design of the ENTRUST-AF PCI trial","volume":"196","author":"P Vranckx","year":"2018","journal-title":"Am Heart J"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","article-title":"Background and data configuration process of a nationwide population-based study using the Korean national health insurance system","volume":"38","author":"SO Song","year":"2014","journal-title":"Diabetes Metab J"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","article-title":"Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Data analytic process of a nationwide population-based study using National Health Information Database established by National Health Insurance Service","volume":"40","author":"YH Lee","year":"2016","journal-title":"Diabetes Metab J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijcard.2016.04.036","article-title":"Underweight is a risk factor for atrial fibrillation: A nationwide population-based study","volume":"215","author":"SH Kang","year":"2016","journal-title":"Int J Cardiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijcard.2016.08.296","article-title":"Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: a nationwide population-based study","volume":"223","author":"SR Lee","year":"2016","journal-title":"Int J Cardiol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"GY Lip","year":"2010","journal-title":"Chest"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.amjcard.2008.08.021","article-title":"Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy","volume":"102","author":"R Rossini","year":"2008","journal-title":"Am J Cardiol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1540-8183.2009.00468.x","article-title":"Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting","volume":"22","author":"A Rubboli","year":"2009","journal-title":"J Interv Cardiol"},{"issue":"15","key":"ref23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/hrt.2008.160457","article-title":"Triple antithrombotic management after stent implantation: when and how?","volume":"95","author":"A Schomig","year":"2009","journal-title":"Heart"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jacc.2016.05.085","article-title":"Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"68","author":"NR Sutton","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"EJ Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"45","key":"ref26","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)","volume":"35","author":"GY Lip","year":"2014","journal-title":"Eur Heart J"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"e004395","DOI":"10.1161\/CIRCINTERVENTIONS.116.004395","article-title":"Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a North American perspective\u2013 2016 update","volume":"9","author":"DJ Angiolillo","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"AY Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2013.08.005","article-title":"Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy","volume":"166","author":"EL Fosbol","year":"2013","journal-title":"Am Heart J"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2013.05.029","article-title":"Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention","volume":"62","author":"M Lamberts","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"e0189495","DOI":"10.1371\/journal.pone.0189495","article-title":"Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: a nationwide population-based study","volume":"12","author":"SR Lee","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.amjcard.2017.06.058","article-title":"Bleeding risk scores in atrial fibrillation and venous thromboembolism","volume":"120","author":"H Zulkifly","year":"2017","journal-title":"Am J Cardiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2017.12.076","article-title":"Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation","volume":"255","author":"D Pastori","year":"2018","journal-title":"Int J Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0209593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:41:26Z","timestamp":1589042486000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0209593"}},"subtitle":[],"editor":[{"given":"Chiara","family":"Lazzeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0209593","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]}}}